MedPath

Zoledronic acid

These highlights do not include all the information needed to use ZOLEDRONIC ACID INJECTION safely and effectively. See full prescribing information for ZOLEDRONIC ACID INJECTION. ZOLEDRONIC ACID injection, for intravenous infusion Initial U.S. Approval: 2001

Approved
Approval ID

fd0324d8-b9bd-fd4c-e053-6394a90a5465

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2023

Manufacturers
FDA

FOSUN PHARMA USA INC

DUNS: 080920998

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zoledronic acid

PRODUCT DETAILS

NDC Product Code72266-152
Application NumberANDA209578
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 7, 2023
Generic NameZoledronic acid

INGREDIENTS (4)

MANNITOLInactive
Quantity: 4950 mg in 100 mL
Code: 3OWL53L36A
Classification: IACT
ZOLEDRONIC ACIDActive
Quantity: 5 mg in 100 mL
Code: 6XC1PAD3KF
Classification: ACTIM
SODIUM CITRATEInactive
Quantity: 30 mg in 100 mL
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zoledronic acid - FDA Drug Approval Details